Anil Singhal - Aug 10, 2023 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ Sean Murphy, Attorney-in-Fact for Anil Singhal
Stock symbol
TLSI
Transactions as of
Aug 10, 2023
Transactions value $
$0
Form type
3
Date filed
8/14/2023, 06:00 PM
Next filing
Aug 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TLSI Stock Option (right to buy) Aug 10, 2023 Common Stock 3.71K $1.22 Direct F1, F2
holding TLSI Stock Option (right to buy) Aug 10, 2023 Common Stock 1.98K $0.41 Direct F2, F3
holding TLSI Stock Option (right to buy) Aug 10, 2023 Common Stock 1.24K $0.41 Direct F2, F4
holding TLSI Stock Option (right to buy) Aug 10, 2023 Common Stock 12.4K $2.43 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option became fully vested on July 24, 2020.
F2 The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming a director of the Issuer. The Reporting Person was appointed as a director of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.).
F3 The shares subject to this stock option shall vest in equal quarterly installments over three years, with 1/12th of the total number of shares subject to the option vesting on each quarterly anniversary of the vesting commencement date of January 1, 2021, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F4 The shares subject to this stock option vest in 48 equal monthly installments from April 15, 2020, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F5 The shares subject to this stock option vest in 48 equal monthly installments from January 19, 2022, the vesting commencement date, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.